HEADER TRANSPORT PROTEIN/RNA 27-FEB-17 5UZZ TITLE STRUCTURE OF WILD TYPE PRE-MIR21 APICAL LOOP COMPND MOL_ID: 1; COMPND 2 MOLECULE: PRE-MIR21; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES; COMPND 5 MOL_ID: 2; COMPND 6 MOLECULE: 14-MER PEPTIDE; COMPND 7 CHAIN: B; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 SYNTHETIC: YES; SOURCE 3 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 MOL_ID: 2; SOURCE 6 SYNTHETIC: YES; SOURCE 7 ORGANISM_SCIENTIFIC: SYNTHETIC CONSTRUCT; SOURCE 8 ORGANISM_TAXID: 32630 KEYWDS MICRORNA MIR-21 ONCOMIR PRE-MIRNA, TRANSPORT PROTEIN-RNA COMPLEX EXPDTA SOLUTION NMR NUMMDL 10 AUTHOR M.D.SHORTRIDGE,G.VARANI REVDAT 4 01-JAN-20 5UZZ 1 REMARK REVDAT 3 13-SEP-17 5UZZ 1 REMARK REVDAT 2 28-JUN-17 5UZZ 1 JRNL REVDAT 1 14-JUN-17 5UZZ 0 JRNL AUTH M.D.SHORTRIDGE,M.J.WALKER,T.PAVELITZ,Y.CHEN,W.YANG,G.VARANI JRNL TITL A MACROCYCLIC PEPTIDE LIGAND BINDS THE ONCOGENIC MICRORNA-21 JRNL TITL 2 PRECURSOR AND SUPPRESSES DICER PROCESSING. JRNL REF ACS CHEM. BIOL. V. 12 1611 2017 JRNL REFN ESSN 1554-8937 JRNL PMID 28437065 JRNL DOI 10.1021/ACSCHEMBIO.7B00180 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR NIH REMARK 3 AUTHORS : SCHWIETERS, KUSZEWSKI, TJANDRA AND CLORE REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5UZZ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 07-MAR-17. REMARK 100 THE DEPOSITION ID IS D_1000226681. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 310; 310 REMARK 210 PH : 6.5; 6.5 REMARK 210 IONIC STRENGTH : 10; 10 REMARK 210 PRESSURE : 1 ATM; 1 ATM REMARK 210 SAMPLE CONTENTS : 0.8 MM PRE-MIR21, 0.8 MM ARG-VAL REMARK 210 -ARG-THR-ARG-GLY-LYS-ARG-ARG-ILE-ARG-ARG-DPR-PRO, 10 MM REMARK 210 POTASSIUM PHOSPHATE, 10 MM SODIUM CHLORIDE, 10 MM EDTA, 100% D2O; REMARK 210 1 MM ARG-VAL-ARG-THR-ARG-GLY-LYS-ARG-ARG-ILE-ARG-ARG-DPR-PRO, REMARK 210 10 MM POTASSIUM PHOSPHATE, 10 MM SODIUM CHLORIDE, 95% H2O/5% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D 1H-1H TOCSY; 2D 1H-1H NOESY; REMARK 210 2D 1H-15N HSQC REMARK 210 SPECTROMETER FIELD STRENGTH : 500 MHZ; 800 MHZ REMARK 210 SPECTROMETER MODEL : DRX; AVANCE III REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : X-PLOR NIH, SPARKY REMARK 210 METHOD USED : SIMULATED ANNEALING REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 200 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 10 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH THE LOWEST REMARK 210 ENERGY REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 N ARG B 1 C PRO B 14 1.33 REMARK 500 HO2' A A 29 O5' C A 30 1.54 REMARK 500 O2' A A 29 H6 C A 30 1.57 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 3 LYS B 7 39.97 39.41 REMARK 500 6 LYS B 7 38.48 37.74 REMARK 500 7 LYS B 7 39.92 35.25 REMARK 500 10 LYS B 7 45.01 -140.30 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 30258 RELATED DB: BMRB REMARK 900 STRUCTURE OF WILD TYPE PRE-MIR21 APICAL LOOP REMARK 900 RELATED ID: 5UZT RELATED DB: PDB REMARK 900 RELATED ID: 5V29 RELATED DB: PDB DBREF 5UZZ A 22 52 PDB 5UZZ 5UZZ 22 52 DBREF 5UZZ B 1 14 PDB 5UZZ 5UZZ 1 14 SEQRES 1 A 31 G G U G U U G A C U G U U SEQRES 2 A 31 G A A U C U C A U G G C A SEQRES 3 A 31 A C A C C SEQRES 1 B 14 ARG VAL ARG THR ARG GLY LYS ARG ARG ILE ARG ARG DPR SEQRES 2 B 14 PRO HET DPR B 13 14 HETNAM DPR D-PROLINE FORMUL 2 DPR C5 H9 N O2 SHEET 1 AA1 2 VAL B 2 ARG B 5 0 SHEET 2 AA1 2 ARG B 8 ARG B 11 -1 O ILE B 10 N ARG B 3 LINK C ARG B 12 N DPR B 13 1555 1555 1.31 LINK C DPR B 13 N PRO B 14 1555 1555 1.31 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL MASTER 108 0 1 0 2 0 0 6 0 0 0 5 END